Applied Genetic Technologies reported $-14241000 in Pre-Tax Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Alimera Sciences ALIM:US $ -3.1M 2.86M
Applied Genetic Technologies AGTC:US $ -14.24M 4.87M
Biogen BIIB:US $ 874.8M 28.6M
Bluebird Bio BLUE:US $ -100.14M 22.01M
Celldex Therapeutics CLDX:US $ -36M 12.95M
Cti Biopharma CTIC:US $ -22.65M 14.52M
Insmed INSM:US $ -95144000 908K
Intercept Pharmaceuticals ICPT:US $ -20.32M 3.04M
Life Technologies LIFE:US $ -12.42M 0.27M
Ophthotech OPHT:US $ -49.26M 14.73M
Rigel Pharmaceuticals RIGL:US $ -13.49M 13.95M
Ultragenyx Pharmaceutical RARE:US $ -157.86M 6.1M